Kiniksa (KNSA) COVID-19 Study for ARDS Fails to Meet Main Goal

Published on 28 Dec 2021 on Zacks

Kiniksa (KNSA) reports that the phase III portion of mavrilimumab???s phase II/III study for...

Read the rest of the article

Start tracking your investments with Statfolio

We expect Fusion Pharmaceuticals FUSN to beat expectations when it reports first-quarter 2024 res...

Zacks via Yahoo Finance 26 Apr 2024

As of April 26, 2024, four stocks in the health care sector could be flashing a real warning to i...

Benzinga 26 Apr 2024

Fusion Pharmaceuticals Inc. (FUSN) closed the most recent trading day at $21.24, moving -0.09% fr...

Zacks via Yahoo Finance 17 Apr 2024

Key Insights Given the large stake in the stock by institutions, Fusion Pharmaceuticals' stock pr...

Simply Wall St. via Yahoo Finance 11 Apr 2024

Fusion Pharmaceuticals Inc. (FUSN) closed the most recent trading day at $21.36, making no change...

Zacks via Yahoo Finance 11 Apr 2024

In this article, we will take a look at 31 European Countries That Offer Citizenship by Descent. ...

Insider Monkey via Yahoo Finance 25 Mar 2024

Fusion Pharmaceuticals FUSN signed a definitive agreement with AstraZeneca AZN. Per the agreement...

Zacks via Yahoo Finance 20 Mar 2024

By Yadarisa Shabong and Manas Mishra (Reuters) -AstraZeneca said on Tuesday it will buy Canadian ...

Reuters via Yahoo Finance 19 Mar 2024

Shares of Fusion Pharmaceuticals Inc. FUSN rose sharply in today’s pre-market trading after the...

Benzinga 19 Mar 2024

Momentum investing is all about the idea of following a stock's recent trend, which can be in eit...

Zacks via Yahoo Finance 15 Jan 2024